ArticleScientific reports2026
Identifying GFAP-expressing cell susceptibility to SARS-CoV-2 infection using human iPSC-derived neural cells.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
Abstract
Neurological manifestations are common in COVID-19. However, a key limitation to understanding the mechanisms and developing new therapeutic approaches is the lack of a suitable testing model. In this study, we developed 2D iPSC-derived neural cells to investigate the mechanism underlying the neurotropism of SARS-CoV-2. After two weeks of differentiation, these cells exhibited several cortical brain cell subtypes, as determined by the transcription levels of key marker genes. Interestingly, this heterogeneity of cellular subtypes is comparable to 10-month-old brain organoids developed in an earlier study. Our 2D neural model was predominantly susceptible to SARS-CoV-2 infection in the astrocyte subpopulation. The expression of SARS-CoV-2 entry factors in the astrocyte subpopulation was further explored. Notably, the cells with high expression of BSG were predominately found in the astrocytes. Taken together, our findings demonstrate the benefits of our 2D iPSC-derived neural cell model in elucidating the neurotropism of SARS-CoV-2 and its underlying mechanisms. This model may also be useful for studying the neurotropism of other viruses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.